Recursion Pharmaceuticals reported Q3 2026 revenue of US$18.55 million and a net loss of US$119.04 million, while ...

Recursion Pharmaceuticals (NASDAQ:RXRX) has counted Nvidia as an investor since 2023 when Jensen Huang's company invested ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive Phase 2 data for oral MEK1/2 inhibitor REC-4881 in familial ...

Anthropic has warned that it may be approaching a stage in artificial intelligence development where AI systems significantly ...

OpenAI CEO Sam Altman says superintelligent AI development must have limits to ensure humans remain in control of their lives ...

A Google DeepMind and Stanford study finds simple shapes like a red heart can push AI models such as GPT-5.4 and Claude ...

Anthropic's amended S-1 says future models may soon hit its threshold for AI-driven recursive self-improvement. No current ...

In an amended S-1/A filing submitted to the SEC on November 2, 2026, Anthropic warned of the possibility that it is ...

In the latest filing related to Anthropic's IPO, the company says RSI could be arriving "imminently," which would mean self-improving AI.

Anthropic has warned that artificial intelligence could soon reach a stage where it significantly accelerates the development of more advanced AI systems. The company disclosed the possibility in an a ...

Tencent's Hunyuan Research Agent version 2.0 made its debut Monday, claiming to have crossed a threshold that has defined the ambition of AI-for-science research for a decade: instead of solving ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $119 million in its third quarter. On a per-share basis, the Salt Lake City-based company ...